Vascular Biology |
From the Department of Pharmacology (J.W.F.), Christian Albrechts University, Kiel, Germany; The Hope Heart Institute (M.G.K., T.N.W.) and the Departments of Pathology (M.G.K., T.N.W.) and Surgery (A.W.C.), University of Washington, Seattle; and the Department of Cardiology (B.L.), University of Münster, Münster, Germany.
Correspondence to Thomas N. Wight, PhD, The Hope Heart Institute, 1124 Columbia St, Suite 783, Seattle, WA 98104. E-mail twight{at}hopeheart.org
AbstractDecorin is a member of the family of small leucine-rich proteoglycans that are present in blood vessels and synthesized by arterial smooth muscle cells (ASMCs). This proteoglycan accumulates in topographically defined regions of atherosclerotic lesions and may play a role in the development of this disease. However, little is known about whether decorin has specific effects on the cellular events that contribute to atherosclerotic lesion formation. In the present study, rat ASMCs were transduced with a retroviral vector (LDSN) that carries the bovine decorin gene. Compared with vector control cells (LXSN), these cells constitutively overexpress decorin, as verified by Northern and Western analysis and by metabolic labeling. Experiments were performed to examine the responsiveness of decorin-overexpressing rat ASMCs to platelet-derived growth factor (PDGF) and transforming growth factor-ß1 (TGF-ß1), 2 growth factors that affect cell proliferation and extracellular matrix production in atherosclerosis. Decorin-overexpressing cells had decreased [3H]thymidine incorporation into DNA and increased the levels of the cyclin-dependent kinase inhibitors p21 and p27 in the first 24 hours of response to serum and PDGF-BB. However, these effects of decorin were not apparent at 48 or 72 hours after plating and did not result in reduced growth of decorin-overexpressing cells in response to serum and PDGF-BB. In contrast, the growth response of decorin-overexpressing ASMCs to TGF-ß1, as well as the expression of TGF-ß1responsive genes, such as plasminogen activator inhibitor-1 and versican (an extracellular matrix proteoglycan), was diminished. These results indicate that decorin selectively inhibits the responsiveness of rat ASMCs to TGF-ß1 and suggests that the induction of constitutive decorin overexpression by ASMCs in vivo may have therapeutic value in the inhibition of TGF-ß1mediated effects on the development of atherosclerotic lesions.
Key Words: transforming growth factor-ß1 cell proliferation extracellular matrix decorin decorin arterial smooth muscle
This article has been cited by other articles:
![]() |
J.-Y. Hwang, P. Y. Johnson, K. R. Braun, A. Hinek, J. W. Fischer, K. D. O'Brien, B. Starcher, A. W. Clowes, M. J. Merrilees, and T. N. Wight Retrovirally Mediated Overexpression of Glycosaminoglycan-Deficient Biglycan in Arterial Smooth Muscle Cells Induces Tropoelastin Synthesis and Elastic Fiber Formation in Vitro and in Neointimae after Vascular Injury Am. J. Pathol., December 1, 2008; 173(6): 1919 - 1928. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Nakashima, T. N. Wight, and K. Sueishi Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans Cardiovasc Res, July 1, 2008; 79(1): 14 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Ferdous, V. M. Wei, R. Iozzo, M. Hook, and K. J. Grande-Allen Decorin-transforming Growth Factor- Interaction Regulates Matrix Organization and Mechanical Characteristics of Three-dimensional Collagen Matrices J. Biol. Chem., December 7, 2007; 282(49): 35887 - 35898. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Fischer Tenascin-C: A key molecule in graft stenosis Cardiovasc Res, June 1, 2007; 74(3): 335 - 336. [Full Text] [PDF] |
||||
![]() |
J. Lefebvre-Lavoie, J. G. Lussier, and C. L. Theoret Profiling of differentially expressed genes in wound margin biopsies of horses using suppression subtractive hybridization Physiol Genomics, July 14, 2005; 22(2): 157 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Wong, N. Nili, and B. H. Strauss In vitro differences between venous and arterial-derived smooth muscle cells: potential modulatory role of decorin Cardiovasc Res, February 15, 2005; 65(3): 702 - 710. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Grisanti, P. Szurman, M. Warga, R. Kaczmarek, F. Ziemssen, O. Tatar, and K. U. Bartz-Schmidt Decorin Modulates Wound Healing in Experimental Glaucoma Filtration Surgery: A Pilot Study Invest. Ophthalmol. Vis. Sci., January 1, 2005; 46(1): 191 - 196. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. W. Fischer, S. A. Steitz, P. Y. Johnson, A. Burke, F. Kolodgie, R. Virmani, C. Giachelli, and T. N. Wight Decorin Promotes Aortic Smooth Muscle Cell Calcification and Colocalizes to Calcified Regions in Human Atherosclerotic Lesions Arterioscler Thromb Vasc Biol, December 1, 2004; 24(12): 2391 - 2396. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Shimizu-Hirota, H. Sasamura, M. Kuroda, E. Kobayashi, M. Hayashi, and T. Saruta Extracellular Matrix Glycoprotein Biglycan Enhances Vascular Smooth Muscle Cell Proliferation and Migration Circ. Res., April 30, 2004; 94(8): 1067 - 1074. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jarvelainen, R. B. Vernon, M. D. Gooden, A. Francki, S. Lara, P. Y. Johnson, M. G. Kinsella, E. H. Sage, and T. N. Wight Overexpression of Decorin by Rat Arterial Smooth Muscle Cells Enhances Contraction of Type I Collagen In Vitro Arterioscler Thromb Vasc Biol, January 1, 2004; 24(1): 67 - 72. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tiede, K. Stoter, C. Petrik, W.-B. Chen, H. Ungefroren, M.-L. Kruse, M. Stoll, T. Unger, and J. W Fischer Angiotensin II AT1-receptor induces biglycan in neonatal cardiac fibroblasts via autocrine release of TGF{beta} in vitro Cardiovasc Res, December 1, 2003; 60(3): 538 - 546. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Troup, C. Njue, E. V. Kliewer, M. Parisien, C. Roskelley, S. Chakravarti, P. J. Roughley, L. C. Murphy, and P. H. Watson Reduced Expression of the Small Leucine-rich Proteoglycans, Lumican, and Decorin Is Associated with Poor Outcome in Node-negative Invasive Breast Cancer Clin. Cancer Res., January 1, 2003; 9(1): 207 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Schaefer, K. Macakova, I. Raslik, M. Micegova, H.-J. Grone, E. Schonherr, H. Robenek, F. G. Echtermeyer, S. Grassel, P. Bruckner, et al. Absence of Decorin Adversely Influences Tubulointerstitial Fibrosis of the Obstructed Kidney by Enhanced Apoptosis and Increased Inflammatory Reaction Am. J. Pathol., March 1, 2002; 160(3): 1181 - 1191. [Abstract] [Full Text] [PDF] |
||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |